Conference Coverage

Chlamydia infections associated with more than a doubling of ovarian cancer risk


 

FROM THE AACR ANNUAL MEETING

Pelvic inflammatory disease caused by chlamydia appears to significantly increase the risk of ovarian cancer, according to research to be presented at the annual meeting of the American Association for Cancer Research.

The finding, replicated in two large databases, suggests that promptly treating the infection might reduce the lifetime risk of developing ovarian cancer, Britton Trabert, PhD, said during a press briefing held in advance of the meeting.

Dr. Britton Trabert, National Cancer Institute, Bethesda, Md.

Dr. Britton Trabert

“Although these findings need to be replicated, they suggest potential ovarian cancer risk reduction through targeted treatment of chlamydia infections,” said Dr. Trabert, the Earl Stadtman Investigator at the National Cancer Institute.

The study portends both promise and challenge, according to Elaine R. Mardis, PhD, who comoderated the session.

Pages

Recommended Reading

College students report perceived barriers to HPV vaccine
MDedge Infectious Disease
Bone marrow transplant cures severe HPV disease in GATA2 immunodeficiency
MDedge Infectious Disease
Primary care residents’ approach to HPV vaccine vary by specialty
MDedge Infectious Disease
Incidence of HPV-associated cancers on the rise
MDedge Infectious Disease
HIV infection linked with death from cervical cancer
MDedge Infectious Disease
Rise in HPV vaccination spurs CIN drop
MDedge Infectious Disease
Missed opportunities abound to give HPV vaccine to adolescent girls
MDedge Infectious Disease
International parental attitudes of HPV vaccination have similarities, differences
MDedge Infectious Disease
Parents have diverse reasons for refusing HPV vaccine for their child
MDedge Infectious Disease
Adolescents with chronic health conditions often undervaccinated
MDedge Infectious Disease